Efficacy and safety of endoscopic hemocoagulase spray in patients with active gastrointestinal bleeding

鲁晓岚,王进海,耿妍,李雪荣,吕海珍,王燕,万晓龙,邹百仓,董蕾

DOI: https://doi.org/10.3969/j.issn.1005-6483.2014.12.017

2014-01-01

Abstract:Objective To evaluate and compare the effect and safety of hemocoagulase andthrombin in endoscopic spray treatment for patients with active gastrointestinal bleeding.Methods A totalof 138 hospitalized patients with active gastrointestinal bleeding were chosen and randomly divided intothree groups,including 46 patients with 2 doses of hemocoagulase,46 patients with 4 doses of hemocoagulase and 46 patients with thrombin.The immediate hemostasis rate,hemostasis time,and prothrombin time(PT),thrombin time(TT),activated partial thromboplastin time(APTT)and fibrinogen(FIB)concentration before and after endoscopic spray treatment were compared in different groups.Adverse reactions wereobserved after endoscopic spray treatment in each group.Results No significant differences in age,gender,illness state,blood routine test and prothrombin time were presented among the groups(P >0.05).The hemostasis time of the hemocoagulase groups was significantly shorter than the thrombin group(P <0.05).There were no significant differences in preoperative and postoperative PT,TT,APTT,and FIB among the groups(P >0.05 ).No adverse reactions occurred.Conclusion Endoscopic hemocoagulasespray is more effective and rapid than thrombin in treating patients with active gastrointestinal bleeding.The above doses does not affect the blood coagulation.